SOUTH SAN FRANCISCO, Calif., Dec. 7, 2021 /PRNewswire/ -- Freenome, a privately held biotech company, today announced a Series D funding of $300 million. This brings the company's total ... 原文链接
本文新闻来源www.prnewswire.com,版权归原作者所有,内容仅代表作者本人观点,不代表企查查的立场。如有任何疑问或需要删除,请联系
kefu@qichacha.com